Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)

SHA:688062 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,442	1,193	1,651	2,491	96.54	305.17
Short-Term Investments	-	35.87	35.26	-	-	-
Trading Asset Securities	40.09	3.77	14.88	60.12	-	242.74
Cash & Short-Term Investments	1,482	1,232	1,701	2,551	96.54	547.92
Cash Growth	-6.52%	-27.56%	-33.32%	2542.47%	-82.38%	1241.79%
Accounts Receivable	57.29	38.34	17.51	0.07	0.14	0.23
Other Receivables	127.38	100.05	112.27	82.65	33.01	51.7
Receivables	184.67	138.39	129.78	82.73	33.15	51.92
Inventory	198.56	211.68	159.3	79.05	40.11	34.79
Other Current Assets	79.85	122.84	57.48	65.12	74.93	32.55
Total Current Assets	1,945	1,705	2,048	2,778	244.74	667.18
Property, Plant & Equipment	2,004	2,053	1,935	1,263	811.64	517.34
Long-Term Investments	93.93	46.66	41.95	20.2	18.95	-
Goodwill	118.77	118.77	118.77	118.77	118.77	118.77
Other Intangible Assets	148.19	152.81	139.72	161.31	179.4	191.5
Long-Term Deferred Charges	6.67	6.39	0.98	6.13	12.71	19.49
Other Long-Term Assets	210.45	192.76	170.98	271.93	209.07	124.61
Total Assets	4,527	4,276	4,455	4,619	1,595	1,639
Accounts Payable	144.53	100.23	62.32	45.21	39.69	22.56
Accrued Expenses	74.09	153.03	138.12	82.25	57.53	26.07
Short-Term Debt	1,219	921.6	209.27	100.14	10.82	50.04
Current Portion of Long-Term Debt	264.56	113.65	1.59	0.6	0.15	-
Current Portion of Leases	-	31.52	26.96	21.02	18.83	-
Current Income Taxes Payable	44.58	-	3.34	-	-	-
Current Unearned Revenue	224.77	36.01	13.52	36.65	63.53	6.2
Other Current Liabilities	186.8	185.67	361.26	159.27	79.85	61.97
Total Current Liabilities	2,158	1,542	816.39	445.14	270.41	166.84
Long-Term Debt	948.76	1,006	887.72	492.12	132.05	-
Long-Term Leases	117.32	142.97	167.11	160.57	172.72	-
Long-Term Unearned Revenue	30.12	27.07	10.59	11.03	11.47	1.61
Other Long-Term Liabilities	327.28	1.53	-	-	-	-
Total Liabilities	3,582	2,720	1,882	1,109	586.65	168.45
Common Stock	399.6	399.6	399.6	399.6	299.7	299.7
Additional Paid-In Capital	5,760	5,959	5,931	5,812	2,456	2,146
Retained Earnings	-5,393	-4,795	-3,751	-2,698	-1,743	-973.1
Comprehensive Income & Other	5.08	5.08	4.8	1.56	-2.6	-1.75
Total Common Equity	761.1	1,569	2,584	3,516	1,011	1,471
Minority Interest	184.48	-13.1	-10.45	-5.08	-2.18	-0.21
Shareholders' Equity	945.58	1,556	2,573	3,511	1,009	1,470
Total Liabilities & Equity	4,527	4,276	4,455	4,619	1,595	1,639
Total Debt	2,549	2,216	1,293	774.45	334.58	50.04
Net Cash (Debt)	-1,067	-983.91	408.4	1,777	-238.03	497.88
Net Cash Growth	-	-	-77.01%	-	-	1119.24%
Net Cash Per Share	-2.67	-2.46	1.02	4.54	-0.79	1.75
Filing Date Shares Outstanding	399.4	399.6	399.6	399.6	299.7	299.7
Total Common Shares Outstanding	399.4	399.6	399.6	399.6	299.7	299.7
Working Capital	-212.99	163.47	1,231	2,333	-25.68	500.34
Book Value Per Share	1.91	3.93	6.47	8.80	3.37	4.91
Tangible Book Value	494.14	1,297	2,325	3,236	712.64	1,160
Tangible Book Value Per Share	1.24	3.25	5.82	8.10	2.38	3.87
Buildings	-	753.02	181.83	3.06	3.06	3.06
Machinery	-	1,206	653.69	440.39	420.08	394.01
Construction In Progress	-	240.87	1,131	804.49	313.24	192.2

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.